WallStreetZenWallStreetZen

NASDAQ: FBLG
Fibrobiologics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Fibrobiologics earnings were -$18.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest FBLG earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$4.1M, down 17.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, FBLG reported annual earnings of -$18.6M, with 67.1% growth.

FBLG earnings history

Current Revenue
$0.0
Current Earnings
-$18.1M
Current Profit Margin
0%

FBLG Return on Equity

Current Company
-536.8%
Current Industry
0.3%
Current Market
38.7%
FBLG's Return on Equity (-536.8%)... subscribe to Premium to read more.
High Return on Equity Performance

FBLG Return on Assets

Current Company
-225.1%
Current Industry
-3.2%
FBLG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when FBLG announces earnings.

FBLG Return on Capital Employed

Current Company
-313.58%
Current Industry
-1.8%
FBLG's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FBLG vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
FBLG-$17.06M-$18.14MN/A-$5.19
LIMN-$10.88M-$11.00MN/A-$0.44
CDIO-$6.27M-$6.65MN/A-$3.38
DRMA-$7.10M-$7.10MN/A-$5.31
SILO-$4.79M-$4.84MN/A-$6.45
View Top Biotech Stocks

Fibrobiologics Earnings Reports & History FAQ

What were Fibrobiologics's earnings last quarter?

On FBLG's earnings call on Jul 30, 2026, Fibrobiologics (NASDAQ: FBLG) reported Q2 2026 earnings per share (EPS) of -$0.66, up 72.61% year over year. Total FBLG earnings for the quarter were -$4.12 million. In the same quarter last year, Fibrobiologics's earnings per share (EPS) was -$2.41.

If you're new to stock investing, here's how to buy Fibrobiologics stock.

Is Fibrobiologics profitable or losing money?

As of the last Fibrobiologics earnings report, Fibrobiologics is currently losing money. Fibrobiologics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$18.14 million, a 37.18% increase year over year.

What was FBLG's earnings growth in the past year?

As of Fibrobiologics's earnings date in Jul 30, 2026, Fibrobiologics's earnings has grown year over year. FBLG earnings in the past year totalled -$18.14 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.